Suzy Dilly News Today

Investegate announcements from Proposed Appointment of Non-Executive Director

Scientists at Dundee university have helped discover a way to stop active cancer cells in their tracks – so they can be eliminated by drug…

Investegate announcements from ValiRx PLC, Live Shareholder Q&A and industry events

Investegate announcements from ValiRx PLC, Successful evaluation of breast cancer programme

ValiRx had previously expected to receive the first payments from the intended sub-licence with TheoremRx by the end of 2021

27 April 2021 | 08:46am StockMarketWire.com - Clinical-stage drug development company ValiRx narrowed full-year losses after it cut back on R&D and administrative spending. Pre-tax losses for the year through December amounted to £1.54 million, compared to year-on-year losses of £2.7 million. The company said it had launched a new strategy and implemented structural changes to develop a risk-diversified approach to early-stage drug development. A phase 1/2 clinical trial close out and reporti...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...